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Novel advanced MRI techniques are investigated in patients treated for head and neck
tumors as conventional anatomical MRI is unreliable to differentiate tumor from treatment
related imaging changes.
Purpose
As the diagnostic accuracy of MRI techniques to detect tumor residual or recurrence during
or after treatment is variable reported in the literature, we performed a systematic meta-
analysis.
Data sources
Pubmed, EMBASE and Web of Science were searched from their first record to September
23th 2014.
Study selection
Studies reporting diagnostic accuracy of anatomical, ADC, perfusion or spectroscopy to
identify tumor response confirmed by histology or follow-up in treated patients for head and
neck tumors were selected by two authors independently.
Data analysis
Two authors independently performed data extraction including true positives, false posi-
tives, true negatives, false negatives and general study characteristics. Meta-analysis was
performed using bivariate random effect models when5 studies per test were included.
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Data synthesis
We identified 16 relevant studies with anatomical MRI and ADC. No perfusion or spectros-
copy studies were identified. Pooled analysis of anatomical MRI of the primary site (11 stud-
ies, N = 854) displayed a sensitivity of 84% (95%CI 72–92) and specificity of 82% (71–89).
ADC of the primary site (6 studies, N = 287) showed a pooled sensitivity of 89% (74–96) and
specificity of 86% (69–94).
Limitations
Main limitation are the low, but comparable quality of the included studies and the variability
between the studies.
Conclusions
The higher diagnostic accuracy of ADC values over anatomical MRI for the primary tumor
location emphases the relevance to include DWI with ADC for response evaluation of
treated head and neck tumor patients.
Introduction
Head and neck tumors are a devastating disease being the seventh leading cancer with respect
to incidence, and the eight with respect to mortality rates [1]. Incidence in developing coun-
tries compared to developed countries is even higher [2]. Patients with head and neck tumors
follow an intensive and expensive treatment regime most often consisting of concomitant che-
moradiotherapy. Surgery is not standard in the majority of the patients with locally advanced
tumors, but is frequently performed in other patients groups [3]. Side effects of treatment are
substantial which impacts quality of life [4]. Furthermore, many of the patients with locally
advanced tumors demonstrate an inadequate treatment response [5]. Imaging follow-up is
thus essential to evaluate treatment response and to tailor treatment in individual patients.
Conventional anatomical MRI techniques are commonly used for treatment evaluation,
but are often not able to reliable identify treatment response [6]. Surgery as well as chemora-
diotherapy induces false positive results by changes in the affected area, including fibrosis and
necrosis [7]. These benign treatment induced changes should be differentiated from true resid-
ual or recurrent tumor on imaging to prevent unjustly discontinuation or initiation of therapy.
On the other hand, missing a residual or recurrent tumor also results in inadequate treatment
for the patient.
Several recent studies have shown encouraging results using diffusion weighted imaging
(DWI) for the detection of recurrent head and neck tumors, including calculated apparent
diffusion coefficient (ADC) as potential valuable imaging biomarker for treatment response
evaluation [8]. Next, perfusion and magnetic resonance spectroscopy (MRS) are promising
techniques [9,10]. This is further supported by a recent overview [11]. However, an overview
of the diagnostic accuracy for these advanced MRI techniques is not available as systematic
review or meta-analysis [8–11].
This prompted us to conduct a meta-analysis of the diagnostic accuracy of anatomical
and advanced MRI techniques for tumor residual or recurrence in patients treated for head
and neck tumors. We hypothesized that the advanced MRI techniques perform better than
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anatomical MRI techniques in the differentiation of tumor from treatment induced imaging
changes.
Methods
Our systematic review was performed according to the Preferred Reporting Items for System-
atic reviews and Meta-Analyses (PRISMA, see S1 PRISMA Checklist) criteria and the
AMSTAR guidelines [12,13]. Furthermore, the Cochrane handbook for review of diagnostic
test accuracy was used. A review protocol was written prior to the study start (available upon
request).
Data sources and search strategy
PubMed, EMBASE and Web of Science were searched by AH and HW in separate sessions
using the same search strategy from their first records to September 23th 2014. Database key-
words and text words were searched using head and neck tumors, MRI techniques, treatment
options and treatment response including the subcategories and variants of these words as
search terms (see S1 Text). No filters were used, but studies in non-English languages were
excluded manually later. References of included studies were further hand searched. An effort
was made to include unpublished data by searching EMBASE for conference proceeding and
contacting authors of in case insufficient details were described to generate 2x2 tables.
Selection criteria
We searched for studies with patients who were treated for newly diagnosed head and neck
tumors. Studies reporting on patients with tumors (squamous cell carcinoma) of the oral cav-
ity, pharynx or larynx were included. The reference standards should determine the treatment
effect, thus tumor recurrence or e.g. therapy induced changes by clinical follow-up, imaging
follow-up, histology or a combination of these. Studies were included if a 2x2 table could be
constructed for the anatomical or advanced MRI data using the full text or addition requested
data from the authors.
We excluded studies of patients with salivary gland neoplasms, thyroid gland neoplasms,
parathyroid neoplasms, facial neoplasms, esophagus neoplasms or tracheal neoplasms. Studies
in which a MRI system <1.0 Tesla was used were excluded since data differ substantially from
data obtained in the current common clinical practice using MRI systems1.0 Tesla.
Study selection
Study selection, data extraction and study quality assessment was independently done by two
authors (AH and HW) and discrepancies were resolved by discussion. Possible inclusion was
assessed first based upon title and secondly based upon abstract. The full text was assessed for
eligibility if the abstract suggested relevance. Subsequently, the article was included if it fulfilled
the inclusion criteria of our study. References of included studies were hand searched.
Data extraction and quality assessment
Data extraction was done with the use of a data extraction form. The main data extracted con-
sisted of the number of true positives, false positives, false negatives and true negatives. We
further extracted data on study design, total number of patients, number of males/females,
mean and range of patients’ age, patient selection criteria, imaging characteristics, reference
standard (histology/ imaging follow-up/ clinical follow up) and definition of tumor or treat-
ment changes. In case of incomplete 2x2 tables, the corresponding author was contacted and
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requested to provide the required data to generate 2x2 tables. The quality of included studies
was assessed using the quality assessment of diagnostic accuracy studies, QUADAS-2 [14].
Data synthesis
Sensitivity and specificity with 95% confidence interval (CI) were generated for anatomical
MRI and advanced MRI with RevMan 5.3 (Cochrane collaboration, Copenhagen, Denmark).
When several time points were measured in one study, we used the one that was closest to 6
weeks posttreatment for the main analysis, because that is the most commonly used imaging
follow-up based on our experience. Furthermore, diagnostic accuracy was evaluated in sub-
groups for the intratreatment, early posttreatment and late posttreatment scan moment. These
were set at 2 weeks after the start of treatment, 6 weeks after the end of treatment and3
months after the end of treatment or the most nearing time.
Bivariate random effects models [15] were used to generate pooled estimates of the sensitiv-
ity, specificity, positive likelihood ratio and negative likelihood ratios with a 95% confidence
interval for each index test when 5 or more studies were included. The sensitivity and specific-
ity were displayed together with a hierarchical summary receiver operator curve (HSROC).
We fitted meta-regression in bivariate models and compared sensitivity and specificity of ana-
tomical MRI versus ADC with a likelihood ratio test. The direct comparisons of MRI tech-
niques per study was tested with a two-sample Z test for proportions. The metandi module
was used for meta-analysis of diagnostic test accuracy studies in STATA version 12.1
(College Station, Texas, USA). As suggested by the Cochrane Diagnostic Test Accuracy group,
no analyses of study heterogeneity or funnel plot asymmetry were performed, as these tests are
inaccurate. However, our used random effects model takes heterogeneity into account. Het-
erogeneity was assessed by visual inspection of the forest plots. We evaluated whether differ-
ences in selection (high risk population versus follow-up of all patients) could explain
identified heterogeneity. In case of outliers we evaluated whether bias of specific study charac-
teristics could explain the result and performed sensitivity analysis without the outlier to show
the influence on the test outcome.
Potential clinical implication was illustrated by calculating the number of missed tumors
and total misclassifications using the pooled sensitivity and specificity results for a hypothetical
cohort of 100 patients treated for head and neck tumors. Overall prevalence of tumor residual




Our electronic search revealed a total of 2096 unduplicated references, of which 23 references
were eligible for inclusion in the meta-analysis (Fig 1; Tables 1 and 2) [16–38]. Seven refer-
ences were excluded, because authors were unable to provide the requested information to
generate a 2x2 table [32–38]. Two references of the initial 23 were based on the same patient
population [29,30] of which data from the first publication was considered to be leading,
although both were very similar. One reference described two separate populations of patients
[18], group A [18]A and group B [18]B, respectively. This resulted in the inclusion of 16
patients populations (studies) in the meta-analysis with data from 15 references.
The included diffusion studies concerned 1087 patients with a mean age of 48 years and of
whom 78% was male. Mean tumor prevalence was 25% (range 2–83), without differences for
during treatment (range 9–21) or posttreatment tumor prevalence (range 2–83). As the tumor
prevalence was overlapping for studies that performed follow-up of all patients (prevalence
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range 16–65) and studies that selected patients with a suspicion of tumor recurrence or a high
risk population (prevalence range 2–83), we combined these groups in the further analysis. As
some studies described both anatomical and advanced MRI or both primary and nodal sites,
we had a total of 11 studies (854 patients) for anatomical MRI of the primary tumor site, 6
Fig 1. Flow chart literature searches.
https://doi.org/10.1371/journal.pone.0177986.g001
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ADC studies of the primary site (287 patients), 4 anatomical MRI studies of the nodal sites
(310 patients) and 2 ADC studies of the nodal site (68 patients). No studies concerning perfu-
sion or spectroscopy MRI were available. The definition for differentiating tumor from treat-
ment effects was variable between studies and described for each separately (Tables 1 and 2).
Methodological quality of included studies
The methodological quality of the included studies is summarized (Fig 2). In the patient selec-
tion domain, four studies were considered to be of high risk of bias due to inappropriate exclu-
sion criteria as patients with less than a 1 year disease-free follow-up [17] or patients with less
than 2 year follow-up of the primary site were excluded in these studies [24–26]. Requiring
such a long disease-free period creates a selection bias favoring patients without tumor recur-
rence. We considered another six studies to be at high risk of bias because a non-random
selection was carried out as patients with at high risk for recurrence or with a suspicion of
recurrence were included only [18]B,[21,23,27,28,31]. Moreover, in one study it was only
stated that they included nasopharyngeal carcinomas without explicitly mentioning the inclu-
sion of squamous cell carcinomas, providing an additional argument to classify this study as
high risk [31]. Two studies were classified as being of unclear risk of bias due to poor reporting
of inclusion and exclusion criteria [16,29]. The remaining four studies were considered to be
at low risk of bias [18]B,[19,20,22].
In the index test domain a total of nine studies were considered to be of unclear risk as it
was not described whether the results were interpreted without the knowledge of the reference
standard [16,18]A,[18]B,[19,21,22,24,25,28,29]. The other seven studies were classified as low
risk [17,19,20,23,26,27,31].
In the reference standard domain, four studies were classified as being of high risk because
the index test results were known when interpreting the reference standard [18]A,[18]B,
[19,31]. Eight studies were judged as unclear risk because it was unclear whether the results of
the index test were known during the interpretation of the reference standard [16,20,21,24–
28]. The remaining four studies were considered to be at low risk of bias [17,22,23,29].
In the flow and timing domain, 15 studies were considered to be of high risk because not all
patients received the same reference standard [16–20,22–29,31]. Although, a potential bias
might be mild as surgery and imaging follow-up are both likely to provide the correct diagno-
sis. The one remaining study was classified as low risk [21].
Thus, as most studies showed high risk of bias in the domains patient selection and flow
and timing and the index test and reference standard domains were mostly unclear, study
quality was classified as low.
For assessment of applicability, the included participants and setting, the conduct and inter-
pretation of the index test, and the reference standard in each of the included studies were not
doubted to meet the review question. All studies fulfilled the inclusion criteria of the review.
Main findings primary site
The forest plot of the anatomical MRI (11 studies with 854 patients) for the primary tumor
location showed a reasonable homogenous specificity (see S1 Fig). The sensitivity showed
more variation in CI, which were wide in 2 studies [18]B,[19]. No outliers were detected.
Pooled results for anatomical MRI and ADC were calculated for the primary tumor loca-
tion (Table 3 and Fig 3). Pooled anatomical MRI results demonstrated a sensitivity of 84%
(95% CI 72–92) and a specificity of 82% (95% CI 71–89). The positive likelihood ratio was 4.6
(95% CI 2.7–7.9) and the negative likelihood ratio was 0.19 (95% CI 0.10–0.37).
Meta-analysis of diagnostic accuracy of MRI in head and neck tumors
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Fig 2. Risk of bias and applicability concerns summary with for each domain of the QUADAS-2 for
each included study.
https://doi.org/10.1371/journal.pone.0177986.g002
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The forest plot from the ADC (6 studies with 287 patients) showed overlapping confidence
intervals for both the sensitivity and specificity. A higher pooled diagnostic accuracy was
shown (Table 3 and Fig 3) with a sensitivity of 89% (95% CI 74–96), specificity of 86% (95% CI
69–94), positive likelihood ratio of 6.1 (95% CI 2.5–15.1) and negative likelihood ratio of 0.13
(95% CI 0.05–0.34).
Although the pooled sensitivity and specificity of ADC were higher, this difference was not
significant (p = 0.457 and p = 0.626, respectively). Two studies compared the anatomical MRI
for the primary site with the ADC directly. The first study demonstrated a sensitivity of 72%
for anatomical MRI and a sensitivity of 94% for ADC (p = 0.079). Specificity of both tests were
57% and 100%, respectively (p = 0.002) [28]. The second study showed a sensitivity of 75% for
anatomical MRI and a sensitivity of 100% for ADC (p<0.023) and a specificity of 73% and
95%, respectively (p<0.047) [29].
To illustrate the clinical implication of our findings, we calculated the number of missed
tumors and the number of total misclassified patients in a hypothetic population of 100 head
and neck patients with using the residual or recurrent tumor prevalence of 25% found in our
meta-analysis. This calculation showed that follow-up with anatomical MRI would result in 4
missed tumors and 13 patients would receive unjustified treatment. Implementation of ADC









































Pooled diagnostic accuracy results are shown for the anatomical MRI (aMRI) and apparent diffusion coefficient (ADC) for the primary location of the head
and neck tumors. Abbreviations: CI = confidence interval; LR = likelihood ratio; N = number.
https://doi.org/10.1371/journal.pone.0177986.t003
Fig 3. Hierarchical summary receiver operator curves of anatomical MRI and ADC for the primary tumor site.
https://doi.org/10.1371/journal.pone.0177986.g003
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maps, however, would reduce the number of missed tumors to 3 and the number of patients
that receive unjustified treatment to 10.
Main findings nodal site
The forest plot of the data for the nodal site for anatomical MRI (4 studies with 310 patients)
showed small overlapping confidence interval for the sensitivity and specificity with excep-
tion of the sensitivity of one study [29] and the specificity of another study [16] (see S1 Fig).
Nodal sites of the anatomical MRI showed a sensitivity range of 67–90% and a specificity
range of 33–97%, but there were too few studies to calculate pooled estimates. The forest
plot of the ADC of the nodal site (2 studies with 68 patients) showed overlapping, but wide
confidence intervals. ADC showed a sensitivity range of 73–78% and a specificity range of
88–100%.
Two studies compared the nodal site directly [16,29]. The sensitivity was 67% and the
specificity was 73% for anatomical MRI, for the first study [29]. The ADC demonstrated a
non-significant higher diagnostic accuracy with a sensitivity and specificity of 78% and 88%,
respectively (p = 0.601 and p = 0.087, respectively) [29]. Similar results were demonstrated by
the second study with a sensitivity of 87% with a specificity of 33% for the anatomical MRI and
73% and 100% for ADC, respectively (p = 0.338 and p = 0.082) [16].
Imaging time point
Intratreatment evaluation (2 studies with 79 patients), early posttreatment evaluation (3 stud-
ies with 128 patients), and late posttreatment evaluation (8 studies with 726 patients) measure-
ments demonstrated similar diagnostic accuracy for the primary tumor locations for the
anatomical MRI (S2 Fig). The sensitivity range was 76–88%, 58–100% and 56–96%, respec-
tively. The specificity range was 57–74%, 73–90% and 43–95%, respectively. This was further
supported by the pooled results for the late posttreatment point with a sensitivity of 86% (95%
CI 73–93), specificity of 82% (95% CI 67–91), positive likelihood ratio of 4.8 (95% CI 2.3–9.7)
and negative likelihood ratio of 0.17 (95% CI 0.08–0.37).
Intratreatment (3 studies with 218 patients), early posttreatment (1 study with 30 patients)
and late posttreatment (3 studies with 93 patients) diagnostic accuracy values were also compa-
rable for the ADC studies (S2 Fig) but on average higher than for anatomical MRI. The sensi-
tivity was 70–80%, 100% and 85–95%, respectively. The specificity was 64–89%, 95% and 69–
100% respectively.
Discussion
By using the statistical strategy of a systematic meta-analysis, we were able to demonstrate a
benefit of DWI with derived ADC data over anatomical conventional MRI sequences. Pooled
ADC values showed a higher sensitivity (89%) and specificity (86%) than anatomical MRI for
the primary site (84% and 82%, respectively), while similar results were demonstrated for the
fewer studies concerning nodal sites. The higher sensitivity and specificity of ADC values for
tumor recurrence is also confirmed by the few available direct comparisons.
The relation between the performance of the anatomical MRI and ADC has been unclear
till now as most studies reported diagnostic accuracy data of only anatomical MRI [17–19,
24,26,27,31] or of only ADC data [16,21–23]. Only few have investigated both, but in only 2
studies the diagnostic accuracy was reported of both the anatomical MRI and DWI with
derived ADC data for the primary tumor site [28,29]. These direct comparisons are less prone
to bias than indirect comparisons. Both studies confirmed the higher diagnostic accuracy of
ADC data over anatomical MRI found in our meta-analysis for the primary site with a
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statistically significant higher sensitivity and specificity for the ADC [28,29]. A similar higher
diagnostic accuracy was displayed in the two studies with a direct comparison for the nodal
site, although not statistically significant [16,29].
Different ADC thresholds for the differentiation between treatment effects and tumor resid-
ual/recurrence were used ranging from 1.16–1.46 x10-3 mm2/s for absolute values or 14–53%
for relative differences (see also Table 1). This implies that used thresholds cannot be interpo-
lated across hospital sites. Even within studies different cut-off values were used [29,30]. ADC
values are also known to show intratumoral variation with low ADC values for solid tumor
components and high ADC values for necrotic areas, which can be a caveat in drawing regions
of interest [39]. This might be the reason for the different strategies used in the region of inter-
est analyses. Whole tumor volume possibly included necrotic areas [22]. The studies targeting
the most conspicuous area can be assumed to exclude necrosis [23], while necrosis is certainly
excluded for the studies stated to target the most conspicuous area excluding necrosis [27] or
the complete solid component excluding necrosis [16,29]. One study did not provided details
about the region of interest analysis, hindering a judgment about the quality [21].
Despite the variation in thresholds, tumor heterogeneity and different b-values, ADC data
still outperformed anatomical MRI techniques. Because of the limited number of studies we
were not able to assess the diagnostic accuracy of ADC and MRI in various threshold sub-
groups. However, implementation in clinical practice would benefit from standardized and
validated ADC threshold values and region of interest analysis. This lack of standardization
and the current high variability also hinders the generation of an advice regarding the best cut-
off value to be used in clinical practice. Nevertheless, this meta-analysis demonstrate what
many radiologist experience in daily practice, namely that adding a diffusion sequence to the
anatomical sequences enhances treatment evaluation.
Numbers of excluded patients due to susceptibility artefacts in the head and neck area were
provided in some studies (see Tables 1 and 2). This is a known limitation of DWI sequences,
but the current limited data suggest that it is a problem in a minority of the patients. Small
primary tumor size was an exclusion criteria in only two studies [23,25]. The sensitivity and
specificity reported in studies excluding tumors smaller than 6 mm, however, did not show a
significantly higher accuracy over studies without size limitations. Other factors, like claustro-
phobia played a minimal role.
Data for perfusion and spectroscopy studies were searched, but were not available yet for
inclusion in our meta-analysis. Perfusion is, however, feasible and already shows to be able to
predict survival before treatment or predict tumor response early in the treatment [9,40]. The
potential value of perfusion is also shown by high diagnostic accuracies in treatment response
evaluation in patients with brain tumors [41]. Spectroscopy is even less studied although its
feasibility has been demonstrated in head and neck tumors. However, diagnostic accuracy
remains speculative currently [10].
The main analysis included predominantly posttreatment studies, but also a few intra-
treatment studies. Combining both was considered to be justified as MRI aims in both to
identify viable tumor, although the question differs slightly. Intratreatment MRI aims at dif-
ferentiating responders from non-responders to adapt the treatment in non-responders,
while posttreatment MRI is used to select patients for addition therapy when tumor is
shown. The overlapping diagnostic accuracy supports the legitimacy of combining intra-
treatment and posttreatment MRI.
Identifying non-responders and responders early after treatment start or even before treat-
ment would be optimal. The few intratreatment studies in our data suggest a preference for
using ADC data over anatomical MRI for this [17,22,29]. Predicting treatment response before
the start of it also favors ADC for primary and nodal sites [34,37,42]. Although good, the
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performance is until now too variable for wide clinical implication. It might probably benefit
from more precise coregistration to anatomical MRI, but also more clinical trials in a large
population for validation of DWI early after the start of treatment [43]. Identifying the non-
responders with ADC as a potential biomarker early during treatment may enable treatment
tailoring and may avoid possible side-effects of an ineffective and expensive treatment regime
[44]. Prediction of clinical outcome would be of interest as well.
FDG-PET is frequently used for treatment response assessment with high sensitivity but
lower specificity [45]. Compared to FDG-PET, ADC can be performed earlier to assess treat-
ment response. FDG-PET is less reliable in the first months after treatment with false positive
results due to inflammation, granulation and scar tissue [46]. ADC can be performed in this
period, but false positive and false negatives are not fully excluded. True restricted diffusion
can be seen in an abscess or with inflammation, although central enhancement as shown in
tumor would be lacking. Scar tissue can display low ADC but normally in combination with
lack of diffusion restriction. This distinguishes scar tissue from tumor with low values on the
ADC map together with diffusion restriction [47]. Minimal to absent enhancement of scar
tissue helps in further differentiation from tumor. Included studies used ADC values only
for calculations and therefore likely underestimated the accuracy of diffusion weighted MRI.
Combining anatomical MRI with diffusion weighted MRI including b-maps, ADC maps and
post contrast images would probably demonstrate even higher diagnostic accuracy in clinical
practice. The higher specificity (less false positives) of ADC compared to anatomic MRI results
in a reduction of unnecessary and costly initiation of treatment in patients with treatment
related changes. It might also reduce the patients that are false interpreted on anatomical MRI
as having tumor progression resulting in incorrect continuation of therapy. Moreover, the
higher sensitivity (less false negatives) of ADC contributes in decreasing the number of missed
patients with tumor recurrence.
Multimodal imaging with PET/MR systems is a potential area for further research to
increase diagnostic accuracy of treatment response both early after start treatment as well as
later posttreatment [47].
In general, the methodological quality of the included studies was similar, but low. This
might also explain the wider confidence interval in some studies [18]B, but could not provide
a convincing explanation for others [16,19,29]. The heterogeneity of patient selection, refer-
ence standards or relatively small group size might provide additional sources of variation.
This is a reflection of the complexity of the field, however this variation is an important limita-
tion of the current study. Especially the variability in the definition used to identify tumor
residual or recurrence compared to treatment effects as shown in Tables 1 and 2 might be a
limiting factor. Furthermore, as discussed above and also displayed in these tables, different b-
values and ADC thresholds were used in the different studies. Although it still can be con-
cluded that ADC helps in the differentiation of tumor residual or recurrence and treatment
related effects as fibrosis, this variability hinders stronger conclusions and a firm implication
in clinical practice. Further research should also focus on comparing all imaging techniques in
the same population using direct comparisons to ensure a higher quality. In such a study, the
same reference standard should be applied in a consecutive large cohort of patients. This
would also allow subgroup analyses to search for the sources of heterogeneity in the diagnostic
performance of the MRI sequences.
Conclusions
To conclude, a higher diagnostic accuracy of ADC values over anatomical MRI in patients
with treated head and neck tumors is demonstrated in this meta-analysis. It is should be kept
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in mind that this was only statistically significant for the direct comparison of the primary
tumor site and not convincing for the direct comparisons of the nodal site. However, this
emphases the relevance to include DWI with ADC for response evaluation of treated head and
neck tumor patients.
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